T helper 2-dominant antilymphoma immune response is associated with fatal outcome.

Abstract:

:The precise role of the endogenous immune system in modulating cancer development remains unclear. Tumor cells are generally thought to be nonimmunogenic because they are of 'self' origin. However, tumor-reactive lymphocytes can be isolated from patients with many types of cancer. It is unclear what role these lymphocytes play and why they fail to protect the host. Using a murine B-cell leukemia/lymphoma (BCL1) model, we showed the development of a vigorous antitumor T-cell response in the tumor-susceptible host. Specific T-cell responses against BCL1 developed as early as day 4. However, the nature of this nonprotective response is different from the protective response produced in a major histocompatibility complex-matched tumor-resistant host. Susceptible hosts developed a T helper 2 (Th2)-dominant response, whereas resistant hosts developed a Th1-dominant response to BCL1. Cytolytic activity against BCL1 developed in both resistant and susceptible hosts, but in the susceptible host, this response was weaker and delayed compared with that in the resistant host. Thus, tumor susceptibility does not necessarily mean the absence of an antitumor immune response. Rather, the nature of the antitumor immune response is critical in determining clinical outcome.

journal_name

Blood

journal_title

Blood

authors

Lee PP,Zeng D,McCaulay AE,Chen YF,Geiler C,Umetsu DT,Chao NJ

subject

Has Abstract

pub_date

1997-08-15 00:00:00

pages

1611-7

issue

4

eissn

0006-4971

issn

1528-0020

journal_volume

90

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Chloroma (granulocytic sarcoma) without evidence of leukemia: facilitated light microscopic diagnosis.

    abstract::Localized tumors composed of immature cells of the myelogenous series have been recognized for many years as an uncommon manifestation of granulocytic leukemia. The histologic diagnosis of chloroma (granulocytic sarcoma) may be extremely difficult when the myeloblastic cells are poorly differentiated and the tumor lac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McCarty KS Jr,Wortman J,Daly J,Rundles RW,Hanker JS

    更新日期:1980-07-01 00:00:00

  • Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma.

    abstract::Some patients lose chimerism following nonmyeloablative hematopoietic cell transplantation (HCT), yet, surprisingly, enjoy sustained tumor remissions. We hypothesized that host-versus-graft (HVG) alloresponses might induce antitumor effects against recipient tumors. We explored this question in mice by administering r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3949

    authors: Rubio MT,Kim YM,Sachs T,Mapara M,Zhao G,Sykes M

    更新日期:2003-09-15 00:00:00

  • Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

    abstract::Patients with relapsed chronic lymphocytic leukemia (CLL) and high-risk features, such as fludarabine refractoriness, complex karyotype, or abnormalities of chromosome 17p, experience poor outcomes after standard fludaradine-based regimens. Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341032

    authors: Badoux XC,Keating MJ,Wang X,O'Brien SM,Ferrajoli A,Faderl S,Burger J,Koller C,Lerner S,Kantarjian H,Wierda WG

    更新日期:2011-08-25 00:00:00

  • Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis.

    abstract::Hemojuvelin (HJV) positively modulates the iron regulator hepcidin, and its mutations are the major cause of juvenile hemochromatosis (JH), a recessive disease leading to iron overload. Defective HJV reduces hepcidin up-regulation both in humans and in Hjv-deficient mice. To investigate the JH pathogenesis and the fun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-041004

    authors: Silvestri L,Pagani A,Fazi C,Gerardi G,Levi S,Arosio P,Camaschella C

    更新日期:2007-05-15 00:00:00

  • Ultrastructural and biochemical characterization of glycosaminoglycans in HNK-1-positive large granular lymphocytes.

    abstract::Natural killer (NK) cells are large granular lymphocytes (LGLs) that contain distinct lysosomal granules. The present study was undertaken to determine if these lysosomes contain glycosaminoglycans (GAGs) similar to those previously described in myeloid cells. Mononuclear cells from human blood were stained with HNK-1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Parmley RT,Rahemtulla F,Cooper MD,Rodén L

    更新日期:1985-07-01 00:00:00

  • Transcriptional and posttranscriptional modulation of human neutrophil elastase gene expression.

    abstract::Human neutrophil elastase (NE), a 29-Kd potent serine protease stored in azurophilic granules of mature neutrophils, is coded for by the NE gene, a single copy gene with 5 exons spanning a 6-kb segment of chromosome 11 at q14. With the knowledge that the NE gene expression is limited to early myeloid cell differentiat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yoshimura K,Crystal RG

    更新日期:1992-05-15 00:00:00

  • Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

    abstract::Myeloma is a unique hematologic malignancy that exclusively homes in the bone marrow and induces massive osteoclastic bone destruction presumably by producing cytokines that promote the differentiation of the hematopoietic progenitors to osteoclasts (osteoclastogenesis). It is recognized that neighboring bone marrow s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Michigami T,Shimizu N,Williams PJ,Niewolna M,Dallas SL,Mundy GR,Yoneda T

    更新日期:2000-09-01 00:00:00

  • The interaction of platelets with aortic subendothelium: inhibition of adhesion and secretion by prostaglandin I2.

    abstract::We have studied the effect of prostaglandin I2 on platelet turnover, attachment to the subendothelium, and secretion following balloon deendothelialization of the rabbit aorta. Survival of 51Cr-labeled platelets in the balloon-injured animals remained normal. Thirty minutes after injury, there were 4.52 X 10(6) platel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Adelman B,Stemerman MB,Mennell D,Handin RI

    更新日期:1981-08-01 00:00:00

  • Characterization of an oligopeptide chemoattractant receptor on human blood monocytes using a new radioligand.

    abstract::The study of chemoattractant receptors on human monocytes had been limited by the lack of a radioligand suitable for use with the small numbers of cells routinely available from human donors. A new synthetic oligopeptide radioligand f[35S]met-leu-phe, with a higher specific radioactivity than was available with the tr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Benyunes MC,Snyderman R

    更新日期:1984-03-01 00:00:00

  • Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1.

    abstract::Murine IgM monoclonal antibody STRO-1 identifies a cell surface antigen expressed by stromal elements in human bone marrow (BM). STRO-1 binds to approximately 10% of BM mononuclear cells, greater than 95% of which are nucleated erythroid precursors, but does not react with committed progenitor cells (colony-forming un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Simmons PJ,Torok-Storb B

    更新日期:1991-07-01 00:00:00

  • Natural killer T-cell autoreactivity leads to a specialized activation state.

    abstract::Natural killer T (NKT) cells are innate-like T cells that recognize specific microbial antigens and also display autoreactivity to self-antigens. The nature of NKT-cell autoreactive activation remains poorly understood. We show here that the mitogen-activated protein kinase (MAPK) pathway is operative during human NKT...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-157529

    authors: Wang X,Chen X,Rodenkirch L,Simonson W,Wernimont S,Ndonye RM,Veerapen N,Gibson D,Howell AR,Besra GS,Painter GF,Huttenlocher A,Gumperz JE

    更新日期:2008-11-15 00:00:00

  • Glucose-6 phosphate dehydrogenase mutations and haplotypes in various ethnic groups.

    abstract::Mutations that produce glucose-6-phosphate dehydrogenase (G6PD) deficiency have been identified in samples from patients with hemolytic disease in the United States, and in G6PD-deficient samples from Greece, the Canary Islands, the Czech and Slovak Republics, South China, and in samples from the Coriell Cell Reposito...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Xu W,Westwood B,Bartsocas CS,Malcorra-Azpiazu JJ,Indrák K,Beutler E

    更新日期:1995-01-01 00:00:00

  • Amelioration of Sardinian beta0 thalassemia by genetic modifiers.

    abstract::Sardinian beta-thalassemia patients all are homozygotes for the same null allele in the beta-globin gene, but the clinical manifestations are extremely variable in severity. Previous studies have shown that the coinheritance of alpha-thalassemia or the presence of genetic variants that sustain fetal hemoglobin product...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-217901

    authors: Galanello R,Sanna S,Perseu L,Sollaino MC,Satta S,Lai ME,Barella S,Uda M,Usala G,Abecasis GR,Cao A

    更新日期:2009-10-29 00:00:00

  • Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.

    abstract::Keratinocyte growth factor (KGF) is important in tissue repair and wound healing and its administration can abrogate chemical- and radiation-induced tissue damage in rodents. We investigated KGF as a therapeutic agent for the prevention of graft-versus-host disease (GVHD)-induced tissue damage, morbidity, and mortalit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Panoskaltsis-Mortari A,Lacey DL,Vallera DA,Blazar BR

    更新日期:1998-11-15 00:00:00

  • Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

    abstract::Factor IXAlabama is a variant factor IX molecule responsible for a clinically moderate form of hemophilia B. Twenty-five kilobases (kb) of the variant gene, including seven exons coding for the structural protein, were cloned and characterized. The restriction map and the arrangement of coding regions are identical to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Davis LM,McGraw RA,Ware JL,Roberts HR,Stafford DW

    更新日期:1987-01-01 00:00:00

  • Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

    abstract::The present study sought to determine the impact of the route of administration of an adeno-associated virus (AAV) vector encoding human factor IX (hFIX) on the induction of an immune response against the vector and its xenogenic transgene product, hFIX. Increasing doses of AAV-hFIX were administered by different rout...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.12.3733

    authors: Ge Y,Powell S,Van Roey M,McArthur JG

    更新日期:2001-06-15 00:00:00

  • Interleukin 7 worsens graft-versus-host disease.

    abstract::Impaired immune reconstitution has moved to the forefront of clinical problems limiting progress in allogeneic bone marrow transplantation (BMT). The identification of therapies that can enhance immune reconstitution by increasing thymopoiesis is critical to solving this problem. Interleukin 7 (IL-7) is the most poten...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-04-1082

    authors: Sinha ML,Fry TJ,Fowler DH,Miller G,Mackall CL

    更新日期:2002-10-01 00:00:00

  • Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro.

    abstract::Late committed progenitor cells of erythropoiesis, CFU-E (colony-forming unit--erythroid), were isolated from mouse spleens to near homogeneity by a three-step enrichment procedure. The procedure included a four-day pretreatment of bled mice with the antibiotic thiamphenicol, a recovery period of 3 1/2 days, followed ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nijhof W,Wierenga PK,Staal GE,Jansen G

    更新日期:1984-09-01 00:00:00

  • The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation.

    abstract::The CD28 family of receptors (CD28, cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4], inducible costimulator [ICOS], program death-1 [PD-1], and B- and T-lymphocyte attenuator [BTLA]) plays a critical role in controlling the adaptive arm of the immune response. While considerable information is available regarding...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2004-04-1596

    authors: Riley JL,June CH

    更新日期:2005-01-01 00:00:00

  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) is characterized by abnormal megakaryopoiesis and enhanced thrombotic risk. Once-daily low-dose aspirin is the recommended antithrombotic regimen, but accelerated platelet generation may reduce the duration of platelet cyclooxygenase-1 (COX-1) inhibition. We performed a multicenter doubl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004596

    authors: Rocca B,Tosetto A,Betti S,Soldati D,Petrucci G,Rossi E,Timillero A,Cavalca V,Porro B,Iurlo A,Cattaneo D,Bucelli C,Dragani A,Di Ianni M,Ranalli P,Palandri F,Vianelli N,Beggiato E,Lanzarone G,Ruggeri M,Carli G,Ell

    更新日期:2020-07-09 00:00:00

  • Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.

    abstract::Prophylactic treatment in severe hemophilia is very effective but is limited by cost issues. The implementation of 2 different prophylactic regimens in The Netherlands and Sweden since the 1970s may be considered a natural experiment. We compared the costs and outcomes of Dutch intermediate- and Swedish high-dose prop...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-470898

    authors: Fischer K,Steen Carlsson K,Petrini P,Holmström M,Ljung R,van den Berg HM,Berntorp E

    更新日期:2013-08-15 00:00:00

  • Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.

    abstract::We evaluated a treatment strategy targeting both lymphoma cells (by rituximab) and the microenvironment (by thalidomide) in 16 patients with relapsed/refractory mantle cell lymphoma (MCL). Rituximab was administered at 375 mg/m(2) for 4 weekly doses concomitantly with thalidomide (200 mg daily, with a dose increment t...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-03-1091

    authors: Kaufmann H,Raderer M,Wöhrer S,Püspök A,Bankier A,Zielinski C,Chott A,Drach J

    更新日期:2004-10-15 00:00:00

  • Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope.

    abstract::Approximately 25% of patients with hemophilia A develop inhibitory antibodies after treatment with factor VIII. Most of the inhibitory activity is directed against epitopes in the A2 and C2 domains. Anti-A2 inhibitory antibodies recognize a 25-residue segment bounded by R484-I508. Several antigenic residues in this se...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3891

    authors: Parker ET,Healey JF,Barrow RT,Craddock HN,Lollar P

    更新日期:2004-08-01 00:00:00

  • Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

    abstract::Two families of Epstein-Barr virus (EBV), type A and type B, have been defined on the basis of sequence divergence in the EBNA-2 gene. Type A EBV immortalizes B cells more efficiently in vitro and infects immunocompetent individuals more commonly than type B EBV. However, increased rates of infection by type B EBV are...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Frank D,Cesarman E,Liu YF,Michler RE,Knowles DM

    更新日期:1995-03-01 00:00:00

  • Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.

    abstract::In the 2005-01 trial, we have demonstrated that bortezomib-dexamethasone as induction therapy before autologous stem cell transplantation was superior to vincristine-adriamycin-dexamethasone. We conducted a post-hoc analysis to assess the prognostic impact of initial characteristics as well as response to therapy in p...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-08-300863

    authors: Moreau P,Attal M,Pégourié B,Planche L,Hulin C,Facon T,Stoppa AM,Fuzibet JG,Grosbois B,Doyen C,Ketterer N,Sebban C,Kolb B,Chaleteix C,Dib M,Voillat L,Fontan J,Garderet L,Jaubert J,Mathiot C,Esseltine D,Avet-Loise

    更新日期:2011-03-17 00:00:00

  • Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias.

    abstract::We have investigated the structure of the Ig heavy (IGH) chain locus in 309 cases of acute leukemia. Seventy-one cases of B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) were analyzed: in six cases deletion of joining (JH) segments in the presence of cytogenetically normal chromosome 14 was observed. Similar...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dyer MJ,Heward JM,Zani VJ,Buccheri V,Catovsky D

    更新日期:1993-08-01 00:00:00

  • Self-renewal in late-stage erythropoiesis.

    abstract::Extensive in vitro self-renewal of proerythroblasts from the earliest period of definitive erythropoiesis, as reported by England and co-investigators in this issue of Blood, expands the potential role of self-renewal in mammalian hematopoiesis and suggests a possible source of blood cells for clinical treatments. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2010-12-324319

    authors: Koury MJ

    更新日期:2011-03-03 00:00:00

  • High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.

    abstract::We treated 5 patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome and multifocal bone lesions or diffuse bone marrow plasmacytic infiltration with high-dose therapy (HDT) and autologous blood stem cell transplantation. In all cases, the treatment produced...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood.v99.8.3057

    authors: Jaccard A,Royer B,Bordessoule D,Brouet JC,Fermand JP

    更新日期:2002-04-15 00:00:00

  • von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion.

    abstract::Noncovalent association between the von Willebrand factor (VWF) propeptide (VWFpp) and mature VWF aids N-terminal multimerization and protein compartmentalization in storage granules. This association is currently thought to dissipate after secretion into blood. In the present study, we examined this proposition by qu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387548

    authors: Madabhushi SR,Shang C,Dayananda KM,Rittenhouse-Olson K,Murphy M,Ryan TE,Montgomery RR,Neelamegham S

    更新日期:2012-05-17 00:00:00

  • Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

    abstract::Clinical trials have been started with the aim of inducing tumor immunity by blocking the immunosuppressive action of indoleamine-2,3-dioxygenase (IDO) with the IDO2-inhibitor dextro-1-methyl-tryptophan (D-1MT). Here we show that human dendritic cells (DCs) express both IDO-1 and IDO-2, but that only IDO1 mediates try...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-10-116111

    authors: Lob S,Konigsrainer A,Schafer R,Rammensee HG,Opelz G,Terness P

    更新日期:2008-02-15 00:00:00